Exide Industries: Powering India's Battery Revolution From Lead-Acid Legacy to Lithium-Ion Future

Company Overview

Exide Industries Ltd is India's largest lead-acid battery manufacturer and a cornerstone of the country's energy storage ecosystem. Incorporated in 1947, the company has evolved over nearly eight decades into a diversified battery powerhouse with a product range spanning from 2.5Ah to 20,200Ah. Headquartered in Kolkata and part of the RP-Sanjiv Goenka Group, Exide commands a dominant presence across automotive, industrial, and specialty battery segments. The company is now making its most ambitious strategic pivot yet — building India's first large-scale lithium-ion cell manufacturing facility through its subsidiary Exide Energy Solutions Ltd (EESL), positioning itself at the forefront of the EV and clean energy transition.

Listed on both the NSE (EXIDEIND) and BSE (500086), Exide trades at ₹392 per share as of June 1, 2026, commanding a market capitalisation of ₹33,341 crore. The stock has traded in a 52-week range of ₹287 to ₹431, reflecting the market's ongoing debate about near-term earnings pressure versus the long-term lithium-ion opportunity.

Business Segments and Revenue Model

Exide's business model operates across three distinct verticals, each serving different customer needs and market dynamics.

1. B2C Aftermarket Segment

The aftermarket business is Exide's bread and butter — a high-margin, cash-generative segment where the company benefits from strong brand recall built over decades. Exide manufactures batteries for two-wheelers, three-wheelers, four-wheelers, e-rickshaws, UPS systems, and solar applications for the retail trade and aftermarket. This segment benefits from India's growing vehicle parc, where the installed base of vehicles continues to expand, driving steady replacement demand. Exide's Humsafar network — its tertiary distribution backbone — reaches deep into semi-urban and rural India, providing a formidable competitive moat.

2. Institutional B2B Segment

On the OEM and institutional side, Exide supplies batteries to two-wheeler, three-wheeler, and four-wheeler original equipment manufacturers. Beyond automotive OEMs, the company serves critical infrastructure sectors including telecom, railways, power projects, traction, data centres, and industrial UPS. Notably, Exide manufactures specialised submarine batteries for the Indian Navy — a niche capability that underscores its engineering prowess and the trust placed in it by strategic government customers.

3. International Business

Exide exports to over 60 countries, with international operations contributing approximately 8% of standalone revenue. The company manufactures automotive, traction, and UPS batteries for export markets. In FY25, Exide onboarded 14 new distributors for automotive batteries and 28 new accounts for industrial batteries, signalling an aggressive push to expand its global footprint. While the contribution remains modest, the diversification provides a useful hedge against domestic cyclicality.

Financial Performance: A Decade of Steady Growth Under Pressure

Annual Revenue and Profitability Trends

Exide's topline tells a story of consistent but unspectacular growth over the past decade:

Revenue has grown from ₹9,471 crore in FY15 to ₹17,995 crore in FY26, a compound annual growth rate (CAGR) of approximately 6.1% over eleven years. However, the five-year revenue CAGR from FY21 to FY26 stands at approximately 11.7%, which Screener's automated analysis flags as modest for a company of Exide's scale and market position.

The FY22 net profit of ₹4,357 crore (EPS of ₹51.38) was an anomaly — driven largely by other income of ₹3,725 crore, which likely reflected a one-time gain from the partial divestiture of its life insurance subsidiary Exide Life Insurance to HDFC Life. Stripping out this exceptional item, the underlying profitability trend shows operating profit growing from ₹944 crore to ₹1,870 crore over the decade, with operating margins consistently hovering around 10-13%.

Quarterly Performance: Latest Trends

The most recent quarterly data reveals a company navigating near-term headwinds while maintaining operational stability:

Q4 FY26 (Mar 2026) delivered revenue of ₹4,735 crore — the highest quarterly sales figure in the dataset — alongside a net profit of ₹217 crore (EPS of ₹2.53). This represents a 13.5% year-on-year revenue growth compared to ₹4,173 crore in Q4 FY24, though net profit growth was more modest at 16.7% YoY from ₹186 crore.

The June 2025 quarter stood out as the strongest in recent history, with sales of ₹4,695 crore, operating profit of ₹538 crore (OPM of 11%), and net profit of ₹275 crore (EPS of ₹3.21). The September 2025 quarter was weaker, with OPM dipping to 9% and net profit falling to ₹174 crore, likely reflecting seasonal factors and raw material cost pressures.

Interest costs have been trending upward, rising from ₹21 crore in Q1 FY23 to ₹27 crore in Q4 FY26, reflecting increased borrowings for the lithium-ion capex programme. Depreciation has also expanded from ₹131 crore to ₹138 crore per quarter over the same period, as new assets come onstream.

Balance Sheet: Building for the Future

Exide's balance sheet reveals a company in heavy investment mode, with significant capital being deployed into both its traditional business and the lithium-ion venture.

Assets and Liabilities Summary (FY26)

Several critical observations emerge from the balance sheet:

Capital Work in Progress (CWIP) has exploded from ₹525 crore in FY23 to ₹3,938 crore in FY26 — a more than sevenfold increase in three years. This is almost entirely attributable to the construction of the lithium-ion cell manufacturing plant at Bengaluru through Exide Energy Solutions. The sheer scale of CWIP relative to the ₹4,267 crore of fixed assets indicates that once the lithium-ion plant is capitalised, Exide's asset base will roughly double, fundamentally transforming the company's capital structure.

Borrowings peaked at ₹2,017 crore in FY25 before declining to ₹1,575 crore in FY26, suggesting the company is managing its leverage prudently even as it executes a capital-intensive expansion. Screener flags that "company has reduced debt" as a positive, which appears to hold true for the most recent year. However, borrowings have increased significantly from just ₹58 crore in FY15 and ₹196 crore in FY20, reflecting the funding needs of the lithium-ion project.

Reserves have grown impressively from ₹3,756 crore in FY15 to ₹13,820 crore in FY26, representing retained earnings accumulated over more than a decade. The book value per share stands at ₹164, giving the stock a price-to-book ratio of approximately 2.4x at the current market price of ₹392.

The decline in investments from ₹15,816 crore (FY20) to ₹6,131 crore (FY26) reflects the divestiture of the life insurance business, which was a major balance sheet item prior to its sale to HDFC Life.

Cash Flow Analysis: Operational Strength Returns

The FY26 cash flow statement is arguably the most encouraging data point in the entire dataset. Cash from operations surged to ₹2,413 crore — the highest in the company's history — with a CFO-to-operating-profit ratio of 150%, indicating that reported profits are backed by real cash generation. Free cash flow turned positive at ₹1,293 crore after being negative for three consecutive years (FY23-FY25), suggesting that the worst of the capital expenditure cycle may be behind the company in terms of cash drain.

The negative free cash flows of ₹219 crore (FY23), ₹340 crore (FY24), and ₹652 crore (FY25) were the direct consequence of the lithium-ion plant construction. With CWIP stabilising at ₹3,938 crore in FY26 versus ₹3,643 crore in FY25 — an incremental addition of only ₹295 crore — there are signs that the heavy investment phase is reaching its peak. The financing activity of -₹805 crore in FY26 indicates debt repayment, which is a healthy sign.

Key Financial Ratios: Reading Between the Lines

Return Ratios

The secular decline in ROCE from 23% in FY15 to 9% in FY26 is the single most concerning trend in Exide's financial profile. This compression reflects the denominator effect of ballooning capital employed — driven by CWIP for the lithium-ion project — while the numerator (operating profit) has grown more modestly. The current ROCE of 8.79% and ROE of 6.19% are well below the company's historical standards and below what investors typically expect from a branded consumer-facing business.

Screener flags that "company has a low return on equity of 6.30% over last 3 years" as a key concern. However, this must be contextualised: the low ROE is partly a function of the massive equity base (reserves of ₹13,820 crore) and partly because the lithium-ion investment has not yet begun generating returns. Once the lithium-ion plant commences commercial production, the return ratios should improve meaningfully — though the timeline and magnitude remain uncertain.

Working Capital Efficiency

The cash conversion cycle improved dramatically from 74 days in FY25 to 42 days in FY26 — the best in the entire dataset. This was driven by a combination of faster inventory turnover (inventory days falling from 144 to 120) and better payables management (days payable increasing from 105 to 110). This improvement in working capital efficiency directly contributed to the strong operating cash flow generation of ₹2,413 crore in FY26.

Dividend Track Record

Exide has maintained a healthy dividend payout of approximately 20.2%, which Screener identifies as a positive. The dividend payout ratio has fluctuated between 19% and 45% over the past decade, with the FY20 payout of 45% being the highest. At the current price of ₹392, the dividend yield stands at 0.51%, providing modest but consistent income to shareholders.

Valuation: Pricing in the Lithium Promise

At ₹392 per share, Exide trades at:

• Price-to-Earnings (P/E): 38.7x based on trailing twelve-month earnings
• Price-to-Book (P/B): ~2.4x against a book value of ₹164 per share
• Market Capitalisation: ₹33,341 crore
• Dividend Yield: 0.51%

The P/E ratio of 38.7x appears elevated relative to the company's 5-year earnings CAGR of approximately 1.5% (from ₹803 crore in FY21 to ₹860 crore in FY26, excluding the FY22 anomaly). This premium valuation is entirely predicated on the market's expectations for the lithium-ion business, which is yet to generate meaningful revenue.

For context, if Exide were valued purely on its lead-acid business — which generates stable earnings of approximately ₹800-860 crore annually — at a more typical auto-ancillary P/E of 15-20x, the implied valuation would be ₹12,000-17,200 crore, or roughly ₹141-202 per share. The ₹190-250 per share premium the market is assigning (taking the stock from ~₹200 to ₹392) represents the present value of the lithium-ion optionality.

The Lithium-Ion Bet: India's First Gigafactory

The single most important variable for Exide's long-term investment case is the lithium-ion cell manufacturing facility being built by Exide Energy Solutions Ltd (EESL), a wholly-owned subsidiary. Key details:

• Location: Bengaluru, Karnataka
• Technology: Lithium-ion cell manufacturing (likely NMC and LFP chemistries)
• Phase 1 Target: The company has indicated a target capacity that is not publicly disclosed in exact GWh terms in Screener data, but industry estimates suggest Phase 1 of approximately 6-12 GWh
• CWIP of ₹3,938 crore as of FY26 indicates massive capital already deployed
• Target customers: EV OEMs (two-wheelers, three-wheelers, four-wheelers, buses), energy storage systems, and telecom tower backup

The opportunity is enormous. India's EV market is projected to grow at 35-40% CAGR through 2030, and the government's Production Linked Incentive (PLI) scheme for advanced chemistry cells provides direct financial support. Currently, India imports virtually all lithium-ion cells, creating a massive import substitution opportunity.

However, the risks are equally significant:

1. Execution risk: Building a gigafactory is a complex industrial undertaking. Delays and cost overruns are common globally.
2. Technology risk: Lithium-ion chemistry is evolving rapidly. By the time Exide's plant is fully operational, competing technologies (sodium-ion, solid-state) may have advanced significantly.
3. Competition: Reliance Industries, Ola Electric, Amara Raja, and multiple global players are all building or planning lithium-ion cell manufacturing in India.
4. Capital intensity: The lithium-ion business will require sustained capital investment that could keep return ratios depressed for several more years.
5. Customer acquisition: Winning OEM supply contracts requires demonstrating cell quality, consistency, and cost competitiveness — attributes that take years to prove.

Shareholding Pattern: Institutional Confidence Mixed

Current Shareholding (March 2026)

Total Shareholders: 12,03,117

The promoter holding has been rock-solid at 45.99% for the entire period tracked (from FY17 to FY26), reflecting the RP-Sanjiv Goenka Group's long-term commitment to the business. This stability is a positive signal.

However, the FII holding has declined from a peak of 13.57% in March 2024 to 10.30% in March 2026 — a reduction of 327 basis points over two years. This consistent selling by foreign institutional investors suggests concerns about valuation, return ratio dilution, or the uncertain timeline for lithium-ion returns.

On the positive side, DII holding has increased from 17.15% in March 2025 to 19.12% in March 2026, indicating that domestic mutual funds and insurance companies have been accumulating shares, possibly viewing the stock as a long-term value play on India's energy transition.

The public shareholding at 24.59% across 12,03,117 shareholders indicates broad retail participation. The shareholder count has grown dramatically from 98,468 in FY17 to over 12 lakh in FY26, reflecting the stock's popularity among retail investors — though the slight decline from the peak of 13,38,262 in March 2025 suggests some retail disillusionment with the stock's sideways price action.

FII Trend Over Recent Quarters

The FII-to-DII swap is a notable trend. Foreign investors have reduced exposure by 344 basis points from the June 2024 peak of 13.74%, while domestic institutions have added 125 basis points from 17.87% to 19.12% over the same period. This shift from foreign to domestic institutional ownership typically reflects different investment horizons — FIIs tend to be more sensitive to near-term return ratios and valuation multiples, while DIIs may be positioning for the longer-term structural story.

Peer Comparison

Exide operates in the Auto Components & Equipments sub-industry within the broader Consumer Discretionary sector. Its listed peers include Amara Raja Energy & Mobility (the other major Indian lead-acid battery player), Samvardhana Motherson (auto components conglomerate), and other auto ancillary companies.

At a P/E of 38.7x, Exide commands a significant premium over the broader auto components sector, which typically trades at 20-25x earnings. This premium is entirely attributable to the lithium-ion optionality. Amara Raja, which is also pursuing lithium-ion manufacturing, trades at a similar premium, suggesting the market is pricing the energy transition thesis into both stocks.

Exide's market capitalisation of ₹33,341 crore makes it one of the larger companies in the auto components space, though it is significantly smaller than Samvardhana Motherson. The company's inclusion in the Nifty Midcap 100, Nifty 500, BSE 500, BSE Auto, and Nifty Auto indices ensures consistent institutional attention and passive fund flows.

Risk Factors

1. Lithium-Ion Execution Risk

The single biggest risk is that the lithium-ion plant fails to achieve commercial viability on time or on budget. With ₹3,938 crore of CWIP already invested, any significant delays or technology issues could result in substantial value destruction.

2. Lead-Acid Business Maturity

The core lead-acid battery business faces structural headwinds as electric vehicles (which use lithium-ion batteries) gradually replace internal combustion engine vehicles. While this transition will take decades, it means the cash cow business has a finite growth runway.

3. Raw Material Costs

Lead prices constitute a significant portion of Exide's cost base. Volatility in lead prices can compress margins, as evidenced by the OPM dipping to 9% in September 2025. Similarly, lithium, cobalt, and nickel prices will impact the economics of the lithium-ion business.

4. Competitive Intensity

The Indian battery market is becoming increasingly competitive, with both domestic players (Amara Raja, Luminous) and global entrants (CATL, BYD, Panasonic through partnerships) vying for market share across both lead-acid and lithium-ion segments.

5. Valuation Risk

At 38.7x earnings, the stock is priced for perfection in the lithium-ion business. Any disappointment — whether in the form of delays, lower-than-expected capacity utilisation, or pricing pressure — could trigger a significant de-rating.

6. Return Ratio Dilution

If the lithium-ion business takes longer than expected to achieve profitability, the company's ROCE and ROE could remain at current depressed levels (8.79% and 6.19% respectively) for an extended period, potentially leading to valuation compression.

Investment Thesis: Bull and Bear Cases

Bull Case (Target: ₹500-550, ~28-40% upside)

• Lithium-ion plant commences commercial production in FY27/FY28 with initial capacity of 6-12 GWh
• PLI scheme benefits provide direct financial support, improving project economics
• EV adoption accelerates in India, driving rapid capacity utilisation
• Import substitution thesis plays out, with domestic cell manufacturing gaining cost advantages over imports
• Lead-acid business remains stable, providing cash flow to fund growth
• ROCE recovers to 12-15% as lithium-ion revenues scale up
• Consolidated earnings reach ₹1,200-1,500 crore by FY28-FY29, supporting a P/E of 35-40x

Bear Case (Target: ₹280-320, ~18-28% downside)

• Lithium-ion plant faces delays or achieves lower-than-expected capacity utilisation
• Global lithium-ion overcapacity drives down cell prices, compressing margins
• Lead-acid business growth stalls as replacement demand weakens
• Return ratios remain depressed at 8-9% ROCE, leading to multiple compression
• FII selling continues, creating persistent overhang
• Stock de-rates to 25-30x P/E, implying a price of ₹245-295 based on current earnings

Conclusion: A Transformation Story That Demands Patience

Exide Industries is at an inflection point. The company's lead-acid business remains India's largest and most trusted, generating stable cash flows of ₹2,413 crore from operations in FY26 and supporting a healthy dividend payout of 20.2%. The ₹13,820 crore of reserves and manageable debt of ₹1,575 crore provide a solid financial foundation.

However, the low ROCE of 8.79% and ROE of 6.19% reflect a business in heavy investment mode, with ₹3,938 crore of CWIP representing a massive bet on the lithium-ion future. The P/E of 38.7x prices in substantial success for the lithium-ion venture — a venture that has yet to generate a single rupee of revenue.

For investors, Exide represents a high-conviction, long-duration bet on India's energy transition. The risk-reward is asymmetric: if the lithium-ion business delivers, the stock could be a multi-bagger from current levels; if it disappoints, the downside is cushioned by the valuable lead-acid franchise but could still be meaningful given the premium valuation.

The key milestone to watch is the commercial commencement of the lithium-ion plant. Until then, the stock is likely to remain a battleground between long-term believers in India's EV future and near-term value investors frustrated by declining return ratios and premium valuations. At ₹392, you are paying for the future — the question is whether that future arrives on time, on budget, and at scale.